 |
PDBsum entry 2f3k
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.23.16
- HIV-1 retropepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Antimicrob Agents Chemother
50:1518-1521
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Substrate envelope and drug resistance: crystal structure of RO1 in complex with wild-type human immunodeficiency virus type 1 protease.
|
|
M.Prabu-Jeyabalan,
N.M.King,
E.A.Nalivaika,
G.Heilek-Snyder,
N.Cammack,
C.A.Schiffer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In our previous crystallographic studies of human immunodeficiency virus type 1
(HIV-1) protease-substrate complexes, we described a conserved "envelope" that
appears to be important for substrate recognition and the selection of
drug-resistant mutations. In this study, the complex of HIV-1 protease with the
inhibitor RO1 was determined and comparison with the substrate envelope provides
a rationale for mutational patterns.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.Ode,
M.Yokoyama,
T.Kanda,
and
H.Sato
(2011).
Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability.
|
| |
J Mol Model,
17,
391-399.
|
 |
|
|
|
|
 |
Z.Liu,
Y.Wang,
J.Brunzelle,
I.A.Kovari,
and
L.C.Kovari
(2011).
Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.
|
| |
Protein J,
30,
173-183.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.P.Romano,
A.Ali,
W.E.Royer,
and
C.A.Schiffer
(2010).
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.
|
| |
Proc Natl Acad Sci U S A,
107,
20986-20991.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.N.Jorissen,
G.S.Reddy,
A.Ali,
M.D.Altman,
S.Chellappan,
S.G.Anjum,
B.Tidor,
C.A.Schiffer,
T.M.Rana,
and
M.K.Gilson
(2009).
Additivity in the analysis and design of HIV protease inhibitors.
|
| |
J Med Chem,
52,
737-754.
|
 |
|
|
|
|
 |
M.N.Nalam,
and
C.A.Schiffer
(2008).
New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors.
|
| |
Curr Opin HIV AIDS,
3,
642-646.
|
 |
|
|
|
|
 |
M.N.Nalam,
A.Peeters,
T.H.Jonckers,
I.Dierynck,
and
C.A.Schiffer
(2007).
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
| |
J Virol,
81,
9512-9518.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |